Sourcebio Share Discussion Threads

[pngasef] 09/4/2021 13:14

Will SBI pick up Novacyt's lost contract? Maybe I read all this too fast!

[rivaldo] 08/4/2021 09:56

Good to see solid share price progress this week.

Given the recent news flow from Oxford Nanopore - culminating in an IPO later this year for Nanopore - it's worth recalling December's news of the partnership between SBI and Oxford Nanopore:

[samewe] 05/4/2021 10:11

Twice a week LF tests will uncover many asymptomatic cases which will require lab based PCR confirmatory tests which will be
good for SBI.

[scruff1] 05/4/2021 09:28

Looks like they had best get on with acquisition programme asap. I can see the twice a week jobby seeing sbi bypassed. Am I wrong ?

[pngasef] 28/3/2021 22:37

PCR tests are the gold standard however and are MUCH more sensitive by comparison. Direct sequencing of viral nucleic acid also will allow variants to be identified. The tests you mention shall have their place but they are limited too!!

[1pencil] 28/3/2021 15:01

Daily Mail today

5,000 fans in masks pack into Barcelona concert after passing same-day coronavirus test to measure its effectiveness at preventing outbreaks at events

[1pencil] 27/3/2021 15:08

The move to more immediate on the spot testing will surely dent lab based services, TTG for example gained approval on Friday for Virolens ® in Great Britain.

[dibbs] 21/3/2021 22:19

Personally I believe that testing stocks have probably somewhat prematurely gone out of fashion. Testing will be with us for longer and in greater numbers than most investors are projecting. Still a period of decent earnings ahead for SBI and therefore an even larger cash pile and greater scope for acquisitions or a special divi.

[scruff1] 21/3/2021 09:35

thames
I am of a similar mindset. Am erring on the side of out to be honest. I am still holding some but sold most. The things which play on my mind the most 1. How much revenue will testing generate long term? In fact until the results are announced any assumed revenue is guess work though it should be significant. PTP of around £12 m was forecast for FY 2020 and upwards of £50m 2021 (Results should give us some clue). Its then forecast to drop to around £15m.
2. Then that is where we will see what the co. is made of. They will have around £70m cash (I could well be corrected there) and they have made much play about using it for acquisitions. IMO it is the shrewdness of these or otherwise that will define the co. For me it would be more exciting to hear rumblings about these than to hear about testing rugby clubs etc.
3. Its fairly difficult (for me) to judge real market sentiment. Even on a bad day - of which there have been many- the number of shares sold has been relatively modest and PI's like us are notoriously fickle and this is more so since the flight from low interest rates has led to an increase in novice investors. If Griffiths et al start selling then its defo game over for me at any rate.

Big question is if you are thinking of going is before or after results. If they exceed then you will make up some lost ground. If they disappoint I think it would be a major blow and the share price will take a fairly hefty hit wich I wouldnt expect it to recover from until and if any acquisitions take place. Like always its a gamble.

Thats my ha'peth for what its worth. I am sure others will have a diiferent take

[thamestrader] 21/3/2021 08:24

I need to get off the fence with this one. I have a small, but very irritating holding. By the end of this week i want to be IN (and buy a meaningful quantity) or OUT. Need evidence/news to help me decide.

[rivaldo] 21/3/2021 07:47

Nice article in the Times about lockdown winners in general including SBI:



"Testing companies have been among the biggest beneficiaries, working in laboratories in Britain to develop faster and more accurate devices to help lift the restrictions on much of the rest of the economy (Alex Ralph writes). Among those to benefit was SourceBio International, an Aim-quoted company that, like many, has repositioned itself to capitalise on the opportunities from the crisis.

SourceBio, which provides biopsies for the NHS and cold storage services to drug companies, repurposed part of its Nottingham plant to provide polymerase chain reaction testing. Its customers range from Spire Healthcare, the listed private hospitals company, Nuffield Health, the healthcare charity, the Department of Health and Social Care and, more recently, the Rugby Football Union. The tightly held shares have not become a market darling in the same extraordinary vein as Aim-quoted rival Novacyt but the company raised £35 million when it returned to the market last October."

[samewe] 19/3/2021 15:09

I viewed the Vox Markets video, I was disappointed with the interviewer Paul who talked too much instead of asking open questions and letting the CEO of SBI speak.

[scruff1] 19/3/2021 09:44

The results had better be outstanding. Any seeds of doubt and it will be below IPO price for quite some time imo. Anyone think differently?

[scruff1] 18/3/2021 09:20

Its not enthused some. We need to hear s different tune beyond testing to convince

[samewe] 17/3/2021 09:42

I guess SBI decided to bring forward the 2020 Financial report and Q1 update to cheer us up with some good news instead of waiting till end of April. 2 weeks earlier than planned.

[scruff1] 17/3/2021 07:24

Bit slow here - results announced (13th April)

[samewe] 13/3/2021 10:30

DHSC announced on 12/3, 8/2 and 4/2 contract awards to SBI for the amount of £7.6 million each. These announcements were made within 30 days after the award of contract. Therefore we should see £20 million revenue on the DHSC contracts alone in Q1 this year. There are also contracts with MITIE and RFU announced recently.

[brummy_git] 13/3/2021 08:04

Video commentary here guys on SourceBio International - starts 31mins 30secs


www.linkedin.com/posts/paul-hill-a5994116_stocks-to-follow-activity-6776154096014544896-djn1

[james188] 13/3/2021 07:49

Thanks pob69.

This latest agreement is presumably a renewal of the surge capacity agreement that SBI signed with DHSC in December 2020. The company told us in mid January that that contract had a maximum value of £7.6m (essentially the same amount as the latest award) and expired on 13 February 2021. We were also told that the agreement might be extended for a further three months. The award notice does not specify the duration, but the original deal was for around two months.

[scruff1] 12/3/2021 14:31

Its been clear someone has been unlaoding some. Something meaty required

[scorpio51] 12/3/2021 14:20

Looks like it,good find.

[pob69] 12/3/2021 13:44

Is this new, published today?

£8m contract
PCR Testing Services A Contract Award Notice by DEPARTMENT OF HEALTH AND SOCIAL CARE

[brummy_git] 09/3/2021 12:37

Great interview here with Exec Chairman Jay LeCoque

www.voxmarkets.co.uk/articles/sourcebio-chairman-jay-lecoque-discusses-how-the-company-is-addressing-covid-testing-demands-b3aabe5

[rivaldo] 09/3/2021 09:54

Great stuff in the Sport section of today's Times - SBI have replaced Randox since Randox were rubbish.

And the RFU spends an estimated £100,000 per week on COVID-19 testing, so that's almost £5m per annum of high margin extra income for SBI.....



"The RFU and Gallagher Premiership have engaged a new Covid-19 testing company in a bid to speed up the process. Randox Health, the company whose testing error at its laboratory in Northern Ireland led to “huge disruption” at Bath in January, has been replaced by SourceBio International.

Bath placed all players into isolation, closed their training centre at Farleigh House and subjected the facility to a deep clean after being informed of a major Covid-19 outbreak at the club, with 19 positive cases and a further 16 players identified as close contacts.

Randox subsequently discovered that 18 of those 19 cases were actually negative and apologised, blaming “operator error” and assuring the RFU and Premiership Rugby that new “robotic systems” would ensure there was no repeat.

The RFU, which spends an estimated £100,000 per week on testing, confirmed yesterday it had switched to a supplier based in Nottingham that promised a faster turnaround of results.

SourceBio International are testing the England players and management, who gathered yesterday to begin preparations for their Six Nations game against France. The same company is also conducting all tests at Premiership and Greene King IPA Championship clubs.

“We are very pleased to support elite rugby return to play protocols using our state-of-the-art laboratories to allow elite rugby in England to continue to safely operate,” Jay LeCoque, executive chairman of SourceBio International, said.

“We have been at the forefront of Covid-19 testing programmes since the beginning of the pandemic, supporting the NHS and private healthcare groups, but also helping many of our commercial clients to maintain a safe working environment and helping businesses to get back on track.”